Pacira | PCRX - Ativo Circulante





Ativo Circulante Alterar Data
Astellas Pharma JPY 1.42T 19.35B 2026-03
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Cara Therapeutics USD 31.54M 6.9M 2025-12
Coherus Biosciences USD 206.71M 254.25M 2025-12
Heron Therapeutics USD 228.98M 9.08M 2026-03
Ironwood Pharmaceuticals USD 332.29M 58.11M 2026-03
J&J USD 59.77B 601M 2026-06
Ligand Pharmaceuticals USD 865.42M 33.14M 2026-03
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Novo Nordisk DKK 177.32B 4.86B 2026-03
Omeros USD 69.65M 26.53M 2025-06
Pacira USD 514.96M 33.01M 2026-03
Perrigo USD 2.71B 85M 2026-03
Pfizer USD 42.82B 76M 2026-03
Supernus Pharmaceuticals USD 731.58M 87.4M 2026-03
Teva Pharmaceutical Industries USD 13.76B 50M 2026-06
Xeris Pharmaceuticals USD 251.68M 11.37M 2026-03
Zoetis USD 6.47B 294M 2026-03